Date published: 2026-1-7

1-800-457-3801

SCBT Portrait Logo
Seach Input

KIAA1109 Activators

Chemical activators of KIAA1109 can modulate its activity through various signaling pathways by altering phosphorylation states. Forskolin functions by increasing intracellular cyclic AMP (cAMP) levels through the activation of adenylyl cyclase. The rise in cAMP subsequently activates protein kinase A (PKA), which can phosphorylate a range of proteins, including KIAA1109. Similarly, IBMX inhibits phosphodiesterases, thereby preventing cAMP degradation and enhancing PKA activity, which in turn can lead to the phosphorylation and activation of KIAA1109. Dibutyryl-cAMP, a cell-permeable analog of cAMP, bypasses cellular receptors and directly activates PKA. Once activated, PKA can target KIAA1109 among other proteins. Furthermore, Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), a family of enzymes that can phosphorylate serine and threonine residues on target proteins such as KIAA1109.

The activity of KIAA1109 can also be regulated by modulating calcium signaling and protein phosphatase inhibition. Ionomycin and A23187 (Calcimycin) are calcium ionophores that raise intracellular calcium levels, which can activate calcium-dependent protein kinases capable of phosphorylating KIAA1109. Thapsigargin promotes the release of stored calcium from the endoplasmic reticulum by inhibiting the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA), which in turn can activate calcium-dependent kinases that phosphorylate KIAA1109. On the other hand, Calyculin A and Okadaic Acid maintain proteins in a phosphorylated state by inhibiting protein phosphatases such as PP1 and PP2A. This mechanism can lead to an increased phosphorylation status and consequent activation of KIAA1109. Additionally, Epidermal Growth Factor (EGF) triggers receptor-mediated signaling cascades that activate downstream kinases, which may include those that phosphorylate KIAA1109. Lastly, Phosphatidic Acid activates mTOR signaling, which is known to phosphorylate a variety of downstream targets, potentially including KIAA1109, thereby influencing its activation state.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

Isobutylmethylxanthine (IBMX) inhibits phosphodiesterases, leading to an accumulation of cAMP by preventing its degradation. This increase in cAMP can enhance PKA activity, which may phosphorylate and activate KIAA1109.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which could phosphorylate target proteins including KIAA1109 as part of a signaling cascade.

Calyculin A

101932-71-2sc-24000
sc-24000A
10 µg
100 µg
$163.00
$800.00
59
(3)

Calyculin A is a potent inhibitor of protein phosphatases 1 and 2A, which prevents dephosphorylation of proteins, potentially leading to increased phosphorylation status and activation of proteins like KIAA1109.

Okadaic Acid

78111-17-8sc-3513
sc-3513A
sc-3513B
25 µg
100 µg
1 mg
$291.00
$530.00
$1800.00
78
(4)

Okadaic Acid also inhibits protein phosphatases, particularly PP1 and PP2A, thereby maintaining proteins in a phosphorylated and active state. This could maintain or enhance the activation of KIAA1109.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$99.00
$259.00
36
(2)

Anisomycin is a protein synthesis inhibitor that activates stress-activated protein kinases (SAPKs/JNKs), which could phosphorylate and activate KIAA1109 within their signaling pathways.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Ionomycin acts as an ionophore for calcium, increasing intracellular calcium concentrations, which can activate calcium-dependent protein kinases that may target and activate KIAA1109.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to an increase in cytosolic calcium levels. This can activate calcium-dependent kinases that could phosphorylate and activate KIAA1109.

Phosphatidic Acid, Dipalmitoyl

169051-60-9sc-201057
sc-201057B
sc-201057A
100 mg
250 mg
500 mg
$106.00
$244.00
$417.00
(1)

Phosphatidic Acid acts as a signaling lipid that can activate mTOR signaling, potentially leading to the activation of downstream proteins including KIAA1109 through phosphorylation by mTOR or related kinases.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

A23187 is a calcium ionophore that increases intracellular calcium, potentially activating calcium-dependent kinases which could phosphorylate and lead to the activation of KIAA1109.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$47.00
$136.00
$492.00
$4552.00
74
(7)

Dibutyryl-cAMP is a cell-permeable cAMP analog that directly activates PKA, which could then phosphorylate and activate KIAA1109 as a downstream target within the signaling pathway.